1. Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis
- Author
-
Tang S, Cheng Huang, Jie Li, Yingqing Feng, Anping Cai, Ji-Yan C, and Yu-Qing Huang
- Subjects
0301 basic medicine ,Adult ,Male ,medicine.medical_specialty ,Ambulatory blood pressure ,Diastole ,Blood Pressure ,030204 cardiovascular system & hematology ,Pulse Wave Analysis ,Essential hypertension ,Carotid Intima-Media Thickness ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Internal Medicine ,medicine ,Humans ,In patient ,Pulse wave velocity ,Retrospective Studies ,business.industry ,Middle Aged ,medicine.disease ,Atherosclerosis ,Pulse pressure ,Reverse transcription polymerase chain reaction ,MicroRNAs ,030104 developmental biology ,Endocrinology ,Blood pressure ,Cardiology ,Female ,Essential Hypertension ,business ,Biomarkers - Abstract
MicroRNAs (miRs) are key posttranscriptional regulators of gene expression in all eukaryotic cells and have a vital role in the evolution of hypertension and cardiovascular remodelling and, therefore, have emerged as potential biomarkers for cardiovascular disease. We assessed 240 participants, including 60 healthy volunteers with normal carotid intima-media thickness (nCIMT), 60 healthy volunteers with increased CIMT (iCIMT), 60 hypertensive patients with nCIMT and 60 hypertensive patients with iCIMT. All patients underwent measurements of CIMT, carotid-femoral pulse wave velocity (cfPWV) and ambulatory blood pressure (BP) monitoring. Plasma miR-92a expression was quantified by real-time reverse transcription PCR. Correlations between miR-92a expression and BP parameters, CIMT and cfPWV were assessed using the Spearman correlation coefficient. We observed the lowest miR-92a expression (24.59±1.30 vs 27.76±2.13 vs 29.29±1.89 vs 33.76±2.08; P
- Published
- 2016